新天药业(002873.SZ)控股股东新天智药拟减持不超705万股

Group 1 - The core point of the article is that Xintian Pharmaceutical (002873.SZ) announced a plan for its controlling shareholder, Shanghai Xintian Zhiyao Biotechnology Co., Ltd., to reduce its holdings of the company's shares by a maximum of 7.05 million shares between November 11, 2025, and February 10, 2026, which represents 2.9962% of the total share capital after excluding shares in the company's repurchase special account [1]